CatalystPit

ERNAErnexa Therapeutics Inc.

NASDAQ · PHARMACEUTICAL PREPARATIONS
Last close $3.20 · 2026-09-30
ABOUT
ExchangeNASDAQ
SectorHealthcare
IndustryPHARMACEUTICAL PREPARATIONS
Market cap$5.22M
CountryUSA
RECENT INSIDER TRADES
  • 2026-02-17 · Cherington Charles (10% Owner) · BUY
  • 2025-06-11 · Cherington Charles (10% Owner) · BUY
  • 2025-04-04 · Cherington Charles (10% Owner) · BUY
INSTITUTIONAL OWNERSHIP
Institutional holders10
Shares held71,447
Value$279.35K
Percent of shares outstanding4.38%
As of quarter end2026-06-30
RECENT NEWS
  • Ernexa Therapeutics' ERNA-101 selected for flash talk at cancer conference
  • Ernexa Therapeutics CEO Corner Highlights Appointment of Dr. Robert J
  • Ernexa Therapeutics Reports Compelling ERNA-101 Safety Results Across Three Critical IND-Enabling Studies
  • Ernexa Therapeutics Selected for Emerging Track at 2026 Cell & Gene Meeting on the Mesa, Highlighting ERNA-101 and Focused Oncology Strategy
  • Ernexa Therapeutics appoints Robert J. Spiegel to board of directors
CatalystPit
FeaturesComing soonPricingComing soonPrivacyTermsDisclaimerAffiliate TermsContact
2026 CATALYSTPIT · NOT FINANCIAL ADVICE · DELAYED FILINGS
Ernexa Therapeutics Inc. (ERNA) · Stock Price, Insider Trades, Institutional Holdings · CatalystPit